| scholarly article | Q13442814 |
| P2093 | author name string | Mohammed Al-Omran | |
| Subodh Verma | |||
| Thomas F Lindsay | |||
| P2860 | cites work | Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients | Q24555072 |
| Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study | Q24652963 | ||
| Are national cardiac guidelines being applied by vascular surgeons? | Q28165985 | ||
| MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial | Q28214393 | ||
| Peripheral arterial disease detection, awareness, and treatment in primary care | Q28216456 | ||
| Clinical characteristics, risk factors, and medical treatment of 561 patients with peripheral arterial disease followed in an academic vascular surgery clinic | Q28217680 | ||
| Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients | Q29619542 | ||
| A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee | Q29620666 | ||
| Supporting a call to action for peripheral artery disease: insights from two prospective clinical registries | Q33255158 | ||
| Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). | Q33832961 | ||
| Atherosclerotic risk factor reduction in peripheral arterial diseasea: results of a national physician survey | Q34743538 | ||
| Mandate for creation of a national peripheral arterial disease public awareness program: an opportunity to improve cardiovascular health | Q35638365 | ||
| The relationship of cigarette smoking to peripheral arterial disease. | Q35973387 | ||
| Influence of smoking on incidence and prevalence of peripheral arterial disease | Q35995188 | ||
| Canadian Cardiovascular Society Consensus Conference: peripheral arterial disease - executive summary. | Q36290549 | ||
| ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascul | Q36426489 | ||
| Evidence of suboptimal management of cardiovascular risk in patients with type 2 diabetes mellitus and symptomatic atherosclerosis | Q37596406 | ||
| Carotid artery stenosis in peripheral vascular disease | Q40945665 | ||
| Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis | Q41356030 | ||
| Meeting AHA/ACC secondary prevention goals in a vascular surgery practice: an opportunity we cannot afford to miss | Q42683266 | ||
| Suboptimal preventive practices in patients with carotid and peripheral vascular occlusive disease in a tertiary referral setting | Q44655108 | ||
| Mortality over a period of 10 years in patients with peripheral arterial disease | Q46786119 | ||
| Perceptions of Canadian vascular surgeons toward pharmacological risk reduction in patients with peripheral arterial disease. | Q50786043 | ||
| Atherosclerotic risk factor control in patients with peripheral arterial disease. | Q51517444 | ||
| Secondary prevention of arteriosclerosis in lower limb vascular amputees: a missed opportunity. | Q51789120 | ||
| Missed opportunities to treat atherosclerosis in patients undergoing peripheral vascular interventions: insights from the University of Michigan Peripheral Vascular Disease Quality Improvement Initiative (PVD-QI2). | Q52030937 | ||
| Clinical experience with preoperative coronary angiography. | Q52671088 | ||
| Low rates of preventive practices in patients with peripheral vascular disease. | Q53341280 | ||
| AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update | Q57630939 | ||
| Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery Study | Q68076935 | ||
| P433 | issue | 4 | |
| P1104 | number of pages | 5 | |
| P304 | page(s) | 371-375 | |
| P577 | publication date | 2011-07-01 | |
| P1433 | published in | Annals of Saudi Medicine | Q4767864 |
| P1476 | title | Suboptimal use of risk reduction therapy in peripheral arterial disease patients at a major teaching hospital | |
| P478 | volume | 31 |
| Q34949365 | Profile of atherosclerotic risk factors and management in patients of peripheral arterial disease at a tertiary care teaching hospital of north India |
| Q35869541 | The Burden of Major Adverse Cardiac Events and Antiplatelet Prevention in Patients with Coronary or Peripheral Arterial Disease |
Search more.